ABSTRACT
INTRODUCTION
Zinc, atomic number 30, is a metallic transition element is an important trace element in the body. Nearly 10% of the proteins encoded in the mammalian genome require zinc for their proper structure and function. 1, 2 Over 70 zinc metalloenzymes are required for carbohydrate, protein, lipid and nucleic acid metabolism. 3 Other zinc metalloproteins are involved in diverse processes such as cell signalling, gene expression, membrane structure and function, modulation of the redox state of the cell and cellular respiration. 4, 5 Mild zinc deficiencies can cause chronic metabolic derangement leading to or exacerbating immune deficiency, gastrointestinal problems, endocrine disorders, neurologic dysfunction, cancer, accelerated aging and degenerative disease. 6 Loop diuretics are used in numerous conditions such as CHF, HTN, renal diseases and other oedematous conditions. Frusemide causes a decrease in the serum sodium, potassium, calcium and magnesium levels and an increase in serum uric acid and glucose levels. 7 But, there are sparse and inconclusive reports on its effect on serum Zinc levels. 8, 9 Thus, we have investigated the effect of Frusemide on serum and urine Zinc levels in rabbits.
MATERIALS AND METHODS

Experimental animals
The study was approved by the Institutional Animal Ethics Committee. Healthy, adult, male New Zealand White rabbits (1.5-2 kg) were obtained from the Institutional Central Animal House and housed individually in wire bottomed cages, maintained under standard conditions (Temperature=27 ± 2⁰C, Humidity=30-70%, 12 hr lightdark cycle). Standard laboratory pellet diet & water ad libitum was provided and were acclimatized to laboratory conditions for 7 days prior to experimentation. All animal experiments were conducted in accordance with the CPCSEA Guidelines, 2003.
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Experimental design
The animals were randomly divided into 4 groups of 6 animals each. They were administered single intraperitoneal injection of N. saline (control) and Frusemide The serum obtained was stored in vials at -4⁰C till further usage. The urine was also collected from rabbits placed in metabolic cages till 4 hours after drug administration on the same days, filtered and stored at -4⁰C till further usage.
ATOMIC ABSORPTION SPECTROPHOTOMETRY
Serum and urine samples were analysed for Zinc levels on an Atomic Absorption Spectrophotometer (4139-ECIL) and values were obtained in triplicate.
STATISTICAL ANALYSIS
Data is expressed as Mean ± S.E.M. and analyzed using Paired Sample t-test and one-way ANOVA with post hoc Dunnett's test where required. P values <0.05 were considered significant.
RESULTS
EFFECT OF FRUSEMIDE ON SERUM ZINC LEVELS
As shown in Figure 1 , the control group showed insignificant change in serum Zinc levels with a minute reduction by 1.25%, whereas, the test groups (2,3 and 4) showed significant (p<0.001) and dose-dependent reduction in serum Zinc levels by 14.9%, 27.1% and 40.4% after 5, 10 and 15 mg/kg Frusemide injection respectively when compared to their pre-test values.
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It was also observed that the reduction by Frusemide injection in serum Zinc levels was dependent on the pretreatment values. With lower serum Zinc values on Day 1, the reduction was less which increased on 10 th and 20 th day following Zinc supplementation with higher initial Zinc levels. The change had a direct proportion as shown in Figure 2 .
EFFECT OF FRUSEMIDE ON URINARY ZINC EXCRETION
As shown in Table 1 , the mean urine volume in control group was 24.2 ± 1.3 ml. Frusemide injection caused a significant (p<0.001) and dose-dependent increase in urine volume (64.0 ± 6.4, 68.0 ± 5.5, 82.0 ± 10.3 ml) with 5, 10 and 15 mg/kg doses respectively when compared to the control groups. Urinary Zinc concentration in control was 32 ± 0.4 µg/dl which increased to 49 ± 3.3 (p<0.05), 57 ± 4.5 (p<0.001) and 58 ± 5.3 (p<0.001) µg/dl in 5, 10 and 15 mg/kg Frusemide treated rabbits respectively. The changes were statistically significant. Total amount of urinary Zinc was also increased significantly following Frusemide injection; 26.5 ± 3.2 (p<0.01), 39.0 ± 5.1 (p<0.001) and 48.1 ± 9.2 (p<0.001) µg with 5, 10 and 15 mg/kg doses respectively when compared to control (7.5 ± 2.1 µg).
CHANGE IN SERUM ZINC LEVELS (µg/dl) FOLLOWING ZINC SUPPLEMENTATION IN DIET
As shown in Figure 3 , the normal mean serum Zinc levels in pre-treated rabbits (n=24) ranged from 89 to 159 µg/dl (Mean ± S.E.M., 108.2 ± 65.7 µg/dl) on the 1 st day of study. Zinc supplementation in diet caused a gradual rise in serum Zinc levels which reached 268-396 (Mean ± S.E.M., 320.2 ± 25.4) µg/dl on 10 th day; the increase 196% (p<0.01) was significant as compared to 1 st day values. Supplementation for next 10 days further increased the Zinc levels slightly in all the rabbits on 20 th day, ranging from 271 to 420 µg/dl (326.0 ± 26.7 µg/dl, Mean ± S.E.M.). the increase (202%, p<0.01) was statistically similar to the 10 th day. 
DISCUSSION
This is the first study to be dealing with the relationship between Frusemide and Zinc in such detail. Although Zinc is excreted mainly by the gastrointestinal route, 11 it is obvious from the study that Frusemide leads to a highly significant and dose-dependent fall in serum Zinc levels through urinary excretion. The significant rise in urinary excretion of Zinc is inclusive of both the total Zinc content and the urinary Zinc concentration. The regulation of urinary zinc losses is not well understood. Possibly, the shifts in urinary zinc excretion are mediated by adjustments in renal tubular zinc transport. 12 Experiments with cysteine infusion in anesthetized dogs have demonstrated that the nephron is capable of both proximal secretion and distal reabsorption of Zn. 13 Thus, Frusemide might be causing an increase in the proximal tubular secretion of Zinc. The fall in serum Zinc levels is more with initially high serum Zinc levels as compared to initially low serum Zinc levels. Hence, the body tries its best to maintain a constant level of serum Zinc by adjusting the percentage of urinary excretion according to the pre-treatment values.
There are some reports of Zinc toxicity due to chronic exposure in metal industries, 14 excessive supplementation and food poisoning due to storage of food items in galvanised containers. [15] [16] [17] Hence, Frusemide may be used as a therapeutic agent in hyperzincaemia & zinc poisoning.
It is an established fact that loop diuretics can cause hyperglycemia and hyperuricemia. 7 Since, the role of Zinc in insulin synthesis and secretion has been established over the years, [18] [19] [20] [21] it is possible that hypozincaemia caused by chronic Frusemide administration may lead to hyperglycemia in normal individuals and deteriorate the condition further in diabetics.
Both Zinc and Copper must be present in order to minimize oxidative damage in arthritis and in proper functioning of enzymes like Xanthine oxidase and Superoxide dismutase. 22 These enzymes play the prime role in gout. Thus, zinc deficiency might lead to precipitation of an attack of gout and might possibly be one of the mechanisms behind frusemide-induced hyperuricemia. Apart from this, Zinc depletion causing decreased testosterone production may lead to infertility 23, 24 and increased inflammatory response. 25 And, as shown here, administration of Zinc in diet restored the normal serum Zinc levels indicating that supplementation of Zinc with Frusemide might help to prevent these complications.
With respect to the importance of zinc as an essential element and frequency of diuretic treatment, the observed increased urinary losses of zinc deserve further attention. Moreover, it would be advisable to supplement Zinc along with Frusemide therapy to prevent/reduce the latter's adverse effects.
CONCLUSION
Frusemide may be responsible for Zinc depletion. Supplementation of Zinc may help to prevent the same in patients on prolonged Frusemide therapy.
